m3u

NEJM This Week — February 8, 2024

Featuring articles on a phase 3 trial of resmetirom in NASH with liver fibrosis, an antagonist for plaque psoriasis, the neurovascular complications of F. solani meningitis, an

m3u

Nurse Blake

This week, Dr. Drew talks to Nurse Blake, a nurse, creator, advocate, and touring comedian. Blake discusses various topics, including his nurse cruise, the dynamics between nurses and doctors, the tra

m3u

Systemic Gout Uncovered: Primary Care Perspectives and Solutions

Host: John K. Botson, MD, RPh Guest: Xu He, MD Many patients with gout don’t achieve their target urate levels with conventional urate-lowering therapies. Join renowned experts Drs. Xu He and John Bo

m3u

NEJM This Week — February 1, 2024

Featuring articles on an attenuated tetravalent dengue vaccine, skin antisepsis before fracture surgery, in Niemann–Pick Disease type C, in vivo CRISPR-Cas9 treatment for hereditary

m3u

Anderson Cowan & Mike Carano

This week, Dr. Drew talks with Loveline alums, Anderson Cowan and Mike Carano, about their latest project. They share stories about Loveline, discuss the Elon Musk biography and reco

m3u

Is Therapy Worth It?

Host: Richard S. Isaacson, MD Guest: Pierre N. Tariot, MD Guest: Gayatri Devi, MD, MS, FAAN, FACP Alzheimer’s Disease (AD) has historically been a condition associated with more questions than answer

m3u

Expert Answers to Common Questions for Improving the Road to Remission with CAR T-Cell Ther

Guest: Caron A. Jacobson, MD CD19-directed chimeric antigen receptor (CAR) T-cell therapies are the treatment of aggressive non-Hodgkin lymphoma (NHL), offering patients with refracto

m3u

Masterclass in Cardiac Amyloidosis: Disease Spectrum, Diagnosis and Management

Guest: Prem Soman, MD, PhD, MASNC Guest: Sarah Cuddy, MD Guest: Angela Dispenzieri, MD Host: Saurabh Malhotra, MD, MPH Guest: Sharmila Dorbala, MD, MPH, FASNC Guest: Yvonne Eisele, PhD Guest: Mazan Ha

m3u

Primary Biliary Cholangitis: The Phenotype, It Is a Changin'

Host: Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG Guest: Atoosa Rabiee, MD Embark on a comprehensive CME journey through a multiepisodic series on Primary Biliary Cholangitis. From understanding ev

m3u

Primary Biliary Cholangitis vs Primary Sclerosing Cholangitis: Do You Know the Difference?

Host: Marlyn Mayo, MD Guest: Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG Embark on a comprehensive CME journey through a multiepisodic series on Primary Biliary Cholangitis. From understanding evol

m3u

Primary Biliary Cholangitis: A Natural History Lesson

Host: Marlyn Mayo, MD Guest: Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG Embark on a comprehensive CME journey through a multiepisodic series on Primary Biliary Cholangitis. From understanding evol

m3u

Primary Biliary Cholangitis Is Risky Business

Host: Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG Guest: Atoosa Rabiee, MD Embark on a comprehensive CME journey through a multiepisodic series on Primary Biliary Cholangitis. From understanding ev

m3u

Goals of Treatment for Primary Biliary Cholangitis: A Balancing Act

Host: Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG Embark on a comprehensive CME journey through a multiepisodic series on Primary Biliary Cholangitis. From understanding evolving phenotypes to diff

m3u

Walk a Mile in My Shoes

Host: Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG Embark on a comprehensive CME journey through a multiepisodic series on Primary Biliary Cholangitis. From understanding evolving phenotypes to diff

m3u

Treatment for Primary Biliary Cholangitis: Who's on First, Who's on Second?

Host: Atoosa Rabiee, MD Guest: Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG Embark on a comprehensive CME journey through a multiepisodic series on Primary Biliary Cholangitis. From understanding ev

m3u

Your Patient's PBC Treatment: Long-Term Monitoring and Management

Host: Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG Guest: Marlyn Mayo, MD Embark on a comprehensive CME journey through a multiepisodic series on Primary Biliary Cholangitis. From understanding evol

m3u

The Treatment Pipeline for Primary Biliary Cholangitis: Sorting Out the PPARs

Host: Atoosa Rabiee, MD Guest: Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG Embark on a comprehensive CME journey through a multiepisodic series on Primary Biliary Cholangitis. From understanding ev

m3u

The Treatment Pipeline for Primary Biliary Cholangitis: IBAT Inhibition and Beyond

Host: Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG Guest: Marlyn Mayo, MD Embark on a comprehensive CME journey through a multiepisodic series on Primary Biliary Cholangitis. From understanding evol

m3u

Pediatric Narcolepsy: Addressing the Challenges in Its Recognition, Diagnosis, and Manageme

Host: Michael J. Thorpy, MD Guest: Anne Marie Morse, DO Half of children who develop narcolepsy do so before age 16. However, the majority do not get diagnosed in childhood. In fact, many children ar

m3u

The BeAT Goes On: New Data on Improving Symptoms in HFrEF Patients Using Novel Device Thera

Host: William T. Abraham, MD, FACP, FACC, FAHA, FESC, FRCPE Guest: Georges Chahoud, MD, FACC, FAHA, FHFSA, FASE Guest: Patrick J. McCann, MD Even with medical therapy, or GDMT, man

m3u

Sodium Oxybate in the Management of Narcolepsy: One Molecule, Three Formulations – and the

Host: Clete A. Kushida, MD, PhD Guest: Michael J. Thorpy, MD Three different sodium oxybate formulations are available for the management of narcolepsy with/without cataplexy. While they are equally

m3u

Diagnostic Delay and the Critical Role of Personalized Screening Approaches in Cushing’s Sy

Host: Maria Fleseriu, MD, FACE Guest: Martin Reincke, MD Designed with primary care physicians (PCPs) in mind, this continuing medical education activity focuses on efficient screening for Cushing’s

m3u

Recurrence of Cushing’s and the Changing Landscape of Medical Management

Host: Maria Fleseriu, MD, FACE Guest: Richard Auchus, MD Take your endocrinology practice to the next level and gain in-depth knowledge on disease recurrence, treatment options, and

m3u

NEJM This Week — January 25, 2024

Featuring articles on daratumumab in myeloma therapy, the early treatment of patent ductus arteriosus with ibuprofen, measurable residual disease in chronic lymphocytic leukemia, hospital prices for p

m3u

Not Otherwise Specified

The Quiet Revolution in Medical Training. In Season 2 of the NEJM podcast “Not Otherwise Specified” (NOS), host Lisa Rosenbaum delves into multiple facets of a burgeoning revolution in medical trainin

m3u

Kevin Sorbo

This week Dr. Drew talks to actor and producer Kevin Sorbo. Together, they tackle issues within the public school system, contemplate the potential for a significant awakening in America, and analyze

m3u

It’s All About Patient Identification

Host: Renuka Jain, MD “The Changing TAVR Landscape is a comprehensive multiepisodic CME series addressing critical aspects of the evolving transcatheter aortic valve replacement (TAVR) landscape. Jo

m3u

Challenging TAVR Cases

Host: Renuka Jain, MD Guest: Steven Yakubov, MD, MSCAI, FACC “The Changing TAVR Landscape is a comprehensive multiepisodic CME series addressing critical aspects of the evolving transcatheter aortic

m3u

New TAVR Data – New TAVR Talk Track

Host: Hemal Gada, MD “The Changing TAVR Landscape is a comprehensive multiepisodic CME series addressing critical aspects of the evolving transcatheter aortic valve replacement (TAVR) landscape. Joi

m3u

Putting Data into Clinical Practice

Host: Pam R. Taub, MD, FACC, FASPC Guest: Steven Yakubov, MD, MSCAI, FACC “The Changing TAVR Landscape is a comprehensive multiepisodic CME series addressing critical aspects of the evolving transca

m3u

Could Your Patient’s Symptoms Be Acromegaly?

Host: Susan L Samson, MD, PhD, FRCPC, FACE Guest: Kevin C.J. Yuen, MD Elevate your clinical expertise in acromegaly by delving into the latest advances in diagnosis, treatment modalities, and patient

m3u

Refining Screening and Referral in Frontline Care Settings

Host: John K. Botson, MD, RPh Guest: Xu He, MD Many patients with gout don’t achieve their target urate levels with conventional urate-lowering therapies. Join renowned experts Drs. Xu He and John Bo3